SCHEMBL24287425

SCHEMBL24287425

Cc1ccccc1Oc1nc2ccccc2nc1NSc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MRGPRX1 Q96LB2 1/20 0.35
▸ LYN P07948 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ RXFP1 Q9HBX9 2/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287379 0.88 LMNA (0.34) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL24287535 0.83 P2RY1 (0.40) TP53
SCHEMBL26817474 0.73 KDM4E (0.64) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL24287510 0.73 ALDH1A1 (0.39) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL24287258 0.72 ALDH1A1 (0.50) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL24287477 0.69 RXFP1 (0.49) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL28615722 0.68 CYP1A2 (0.36) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL26813123 0.67 ALDH1A1 (0.46) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL24309729 0.65 MEN1 (0.38) ALDH1A1MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL24287430 0.63 AURKA (0.50) ALDH1A1KMT2ASMN1; SMN2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback